Evidence map›Paper›PMID 28661489›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2018

FOXG1 syndrome: genotype-phenotype association in 83 patients with FOXG1 variants.

Diana Mitter, Milka Pringsheim, Marc Kaulisch, Kim Sarah Plümacher, Simone Schröder, Rita Warthemann, Rami Abou Jamra, Martina Baethmann, Thomas Bast, Hans-Martin Büttel and 31 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 1 pooled it
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 1 synthesis or guideline pooled it, 109 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. PLP1-Targeting Antisense Oligonucleotides Improve FOXG1 Syndrome Mice.International journal of molecular sciences · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

41 authors at 20 institutions in 4 countries.

Diana MitterInstitute of Human Genetics, University Hospital Leipzig, Leipzig, Germany.
Milka PringsheimKlinik für Neuropädiatrie und Neurologische Rehabilitation, Epilepsiezentrum für Kinder und Jugendliche, Schön Klinik Vogtareuth, Vogtareuth, Germany.
Marc KaulischDepartment für Forschungs- und Transferservice, Universität Leipzig, Leipzig, Germany.
Kim Sarah PlümacherKlinik für Kinder- und Jugendmedizin, Universitätsmedizin Göttingen, Göttingen, Germany.
Simone SchröderKlinik für Kinder- und Jugendmedizin, Universitätsmedizin Göttingen, Göttingen, Germany.
Rita WarthemannKlinik für Kinder- und Jugendmedizin, Universitätsmedizin Göttingen, Göttingen, Germany.
Rami Abou JamraInstitute of Human Genetics, University Hospital Leipzig, Leipzig, Germany.
Martina BaethmannKinderklinik, Klinikum Dritter Orden, Munich, Germany.
Thomas BastEpilepsiezentrum Kork, Kehl-Kork, Germany.
Hans-Martin BüttelSozialpädiatrisches Zentrum, SLK-Kliniken Heilbronn, Heilbronn, Germany.
Julie S CohenMoser Center for Leukodystrophies and Neurogenetics Service, Kennedy Krieger Institute, Johns Hopkins Medical Institution, Baltimore, Maryland, USA.
Elizabeth ConoverDepartment of Genetic Medicine, Munroe Meyer Institute, University of Nebraska Medical Center Omaha, Omaha, Nebraska, US.
Carolina CourageDivision of Human Genetics, Department of Pediatrics, Inselspital, University of Bern, Bern, Switzerland.
Angelika EgerSozialpädiatrisches Zentrum Leipzig (Frühe Hilfe Leipzig), Leipzig, Germany.
Ali FatemiMoser Center for Leukodystrophies and Neurogenetics Service, Kennedy Krieger Institute, Johns Hopkins Medical Institution, Baltimore, Maryland, USA.
Theresa A GrebeDivision of Genetics and Metabolism, Phoenix Children's Hospital, Phoenix, Arizona, USA.
Natalie S HauserDepartment of Medical Genomics Inova Translational Medicine Institute, Inova Fairfax Hospital, Falls Church, Virginia, USA.
Wolfram HeinritzPraxis für Humangenetik Cottbus, Cottbus, Germany.
Katherine L HelbigDivision of Clinical Genomics, Ambry Genetics, Aliso Viejo, California, USA.
Marion HeruthKlinik für Kinder- und Jugendmedizin, Sana Kliniken Leipziger Land, Borna, Germany.
Dagmar HuhlePraxis für Humangenetik Leipzig, Leipzig, Germany.
Karen HöftKlinik für Kinder- und Jugendmedizin, Klinikum Magdeburg, Magdeburg, Germany.
Stephanie KarchSozialpädiatrisches Zentrum, Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Heidelberg, Heidelberg, Germany.
Gerhard KlugerKlinik für Neuropädiatrie und Neurologische Rehabilitation, Epilepsiezentrum für Kinder und Jugendliche, Schön Klinik Vogtareuth, Vogtareuth, Germany.
G Christoph KorenkeKlinik für Neuropädiatrie und Angeborene Stoffwechselerkrankungen, Elisabeth Kinderkrankenhaus, Klinikum Oldenburg, Oldenburg, Germany.
Johannes R LemkeInstitute of Human Genetics, University Hospital Leipzig, Leipzig, Germany.
Richard E LutzDepartment of Genetic Medicine, Munroe Meyer Institute, University of Nebraska Medical Center Omaha, Omaha, Nebraska, US.
Steffi PatzerKlinik für Kinder- und Jugendmedizin, Krankenhaus St. Elisabeth und St. Barbara, Halle/Saale, Germany.
Isabelle PrehlCeGaT, Tübingen, Germany.
Konstanze HoertnagelCeGaT, Tübingen, Germany.
Keri RamseyCenter For Rare Childhood Disorders, Translational Genomics Research Institute, Phoenix, Arizona, USA.
Tina RatingSozialpädiatrisches Institut, Klinikum Bremen-Mitte, Bremen-Mitte, Germany.
Angelika RießInstitut für Medizinische Genetik und Angewandte Genomik, Universitätsklinikum Tübingen, Tübingen, Germany.
Luis RohenaDivision of Medical Genetics, Department of Pediatrics, San Antonio Military Medical Center, San Antonio, Texas, USA.
Mareike SchimmelKlinik für Kinder und Jugendliche, Klinikum Augsburg, Augsburg, Germany.
Rachel WestmanChildren's Specialty Center, St. Luke's Children's Hospital, Boise, Idaho, USA.
Frank-Martin ZechKlinik für Kinder- und Jugendmedizin, St. Vincenz-Krankenhaus Paderborn, Paderborn, Germany.
Barbara ZollInstitut für Humangenetik, Universitätsmedizin Göttingen, Göttingen, Germany.
Dörthe MalzahnDepartment of Genetic Epidemiology, University Medical Center, Georg-August University Göttingen, Göttingen, Germany.
Birgit ZirnGenetic Counselling and Diagnostic, Genetikum Stuttgart, Stuttgart, Germany.
Knut BrockmannSPZ, Klinik für Kinder- und Jugendmedizin Universitätsmedizin Göttingen, Göttingen, Germany.
Universitätsmedizin Göttingen · DEUniversity Hospital Leipzig · DECeGaT (Germany) · DEKennedy Krieger Institute · USPraxis für Humangenetik · DESchön Klinik Vogtareuth · DEUniversity of Nebraska Medical Center · USAmbry Genetics (United States) · USBrüderkrankenhaus St. Josef Paderborn · DEDiakonie Kork · DEGenetikum · DEInova Fairfax Hospital · USKlinikum Bremen-Mitte · DEKlinikum Magdeburg · DEKlinikum Oldenburg · DEKrankenhaus St. Elisabeth und St. Barbara · DELeipzig University · DEMünchen Klinik · DEPhoenix Children's Hospital · USSana Kliniken Leipziger Land · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PurposeThe study aimed at widening the clinical and genetic spectrum and assessing genotype-phenotype associations in FOXG1 syndrome due to FOXG1 variants.MethodsWe compiled 30 new and 53 reported patients with a heterozygous pathogenic or likely pathogenic variant in FOXG1. We grouped patients according to type and location of the variant. Statistical analysis of molecular and clinical data was performed using Fisher's exact test and a nonparametric multivariate test.ResultsAmong the 30 new patients, we identified 19 novel FOXG1 variants. Among the total group of 83 patients, there were 54 variants: 20 frameshift (37%), 17 missense (31%), 15 nonsense (28%), and 2 in-frame variants (4%). Frameshift and nonsense variants are distributed over all FOXG1 protein domains; missense variants cluster within the conserved forkhead domain. We found a higher phenotypic variability than previously described. Genotype-phenotype association revealed significant differences in psychomotor development and neurological features between FOXG1 genotype groups. More severe phenotypes were associated with truncating FOXG1 variants in the N-terminal domain and the forkhead domain (except conserved site 1) and milder phenotypes with missense variants in the forkhead conserved site 1.ConclusionsThese data may serve for improved interpretation of new FOXG1 sequence variants and well-founded genetic counseling.

Indexed as

Genetic Association StudiesGenetic VariationChildChild, PreschoolDNA Mutational AnalysisFemaleForkhead Transcription FactorsGenotypeHumansMagnetic Resonance ImagingMaleNerve Tissue ProteinsPhenotypePolymorphism, Single NucleotideRett SyndromeForkhead Transcription FactorsFOXG1 protein, humanNerve Tissue Proteins

Identifiers

PMID28661489
OpenAlexW2732815859

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.